Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study
Timothy J. Henrich, Corinna Schreiner, Cheryl Cameron, Louise E. Hogan, Brian Richardson, Rachel L. Rutishauser, Amelia N. Deitchman, Simon N. Chu, Rodney Rogers, Cassandra Thanh, Erica A. Gibson, Arya Zarinsefat, Sonia Bakkour, Francesca Aweeka, Michael P. Busch, Teri Liegler, Christopher C. Baker, Jeffrey M. Milush, Steven G. Deeks, Peter G. Stock
Topics & Concepts
EverolimusMedicinePI3K/AKT/mTOR pathwayTransplantationmTORC1Clinical trialKidney transplantationOncologyInternal medicineProspective cohort studySirolimusPharmacologyBiologySignal transductionBiochemistryHIV/AIDS drug development and treatmentHIV Research and TreatmentRenal Transplantation Outcomes and Treatments